SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-162070
Filing Date
2016-12-14
Accepted
2016-12-14 16:07:56
Documents
3
Period of Report
2016-12-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-23158_18k.htm 8-K 28346
2 EX-99.1 a16-23158_1ex99d1.htm EX-99.1 12404
3 GRAPHIC g231581mmi001.jpg GRAPHIC 4870
  Complete submission text file 0001104659-16-162070.txt   49093
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 162051211
SIC: 2835 In Vitro & In Vivo Diagnostic Substances